CJC-1295 + GHRP-2 Research Blend GHRH Analogue + High-Potency GHS-R1a Agonist · Maximum GH Release Research · ≥99% HPLC · Janoshik COA
CJC-1295 + GHRP-2 is the highest-potency GH axis research combination — GHRP-2 produces the highest GH release of any synthetic secretagogue via GHS-R1a, at the cost of greater cortisol and prolactin elevation versus GHRP-6 or Ipamorelin. Used in research contexts where maximum GH output is the variable rather than hormonal selectivity. QSC stocks both at ≥99% HPLC with Janoshik COA.
CJC-1295 (DAC-modified GHRH analogue) + GHRP-2 (high-potency GHS-R1a hexapeptide) is the maximum-output GH research combination. GHRP-2 produces higher GH release than GHRP-6 or Ipamorelin but with greater cortisol and prolactin elevation. Used when maximum GH output is the primary research variable. QSC stocks both at ≥99% HPLC with Janoshik COA. Research use only.
How does GHRP-2 compare to GHRP-6?
GHRP-2 produces higher total GH release than GHRP-6 via stronger GHS-R1a binding affinity. Both produce cortisol and prolactin elevation (unlike Ipamorelin). GHRP-2 shows greater cortisol and ACTH elevation than GHRP-6. Research protocol choice depends on whether maximum GH output (GHRP-2) or moderated hormonal response (GHRP-6) is the study variable.
Buy CJC-1295 + GHRP-2 Research Blend Components
Both compounds available at ≥99% HPLC · Janoshik Independent COA · verify.janoshik.com
Research Use Only: All QSC products sold strictly for in vitro laboratory research. Not for human or veterinary use. Information on this page is educational and does not constitute medical advice.
